Do Traders Think Vivos Therapeutics Inc (VVOS) Can Turn Around Friday?

Overall market sentiment has been high on Vivos Therapeutics Inc (VVOS) stock lately. VVOS receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Vivos Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VVOS!

See Full VVOS Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With VVOS Stock Today?

Vivos Therapeutics Inc (VVOS) stock has fallen -7.93% while the S&P 500 is up 0.13% as of 10:41 AM on Friday, Apr 1. VVOS has fallen -$0.21 from the previous closing price of $2.68 on volume of 39,233 shares. Over the past year the S&P 500 is up 14.18% while VVOS has fallen -62.80%. VVOS lost -$0.96 per share in the over the last 12 months.

More About Vivos Therapeutics Inc

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists. Click Here to get the full Stock Report for Vivos Therapeutics Inc stock.